《Liver Cancer》重点专注发布Oncology-Medicine领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 16 Weeks 。该杂志创刊至今，在Oncology-Medicine领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 20.8 | 3.599 | 2.917 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Oncology
|
Q1 | 19/404 | 95% | |||
|
大类：大类：Medicine
小类：小类：Hepatology
|
Q1 | 6/82 | 93% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：GASTROENTEROLOGY & HEPATOLOGY | SCIE | Q1 | 9 / 143 | 94.1% |
| 学科：ONCOLOGY | SCIE | Q1 | 23 / 322 | 93% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：GASTROENTEROLOGY & HEPATOLOGY | SCIE | Q1 | 10 / 143 | 93.36% |
| 学科：ONCOLOGY | SCIE | Q1 | 22 / 322 | 93.32% |
文章名称
引用次数
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
91
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
27
Systemic Treatment Options in Hepatocellular Carcinoma
25
Systemic Treatment for Advanced Hepatocellular Carcinoma
22
Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
21
Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment
14
The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong
14
Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma
12
Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients
11
Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
8
国家/地区
发文量
TJapan
69
TCHINA MAINLAND
24
TTaiwan
19
TSouth Korea
18
TUSA
17
TItaly
15
TGERMANY (FED REP GER)
13
TFrance
8
TEngland
5
TAustria
4
